NEW STUDY TO DETECT COLORECTAL CANCER The Catalan Institute of Oncology leads a research project to improve early detection of colorectal cancer. The study, called COLSCREEN, will be performed with the help of the following endoscopy centers: University Hospital of Bellvitge, Viladecans Hospital and Hospital Moisès Broggi. If you want to help us, you will find more […]
This article, whose main author is David Cordero, published in BMC journal, shows how the dysregulation of transcriptional programs leads to cell malfunctioning and can have an impact on cancer development. The study aims to characterize global differences between transcriptional regulatory programs of normal and tumor colon cells. The results show that the tumor network exhibits […]
Recently, the paper Mutanome and expression of immune response genes in microsatellite stable colon cancer has been published in the Oncotarget journal. The first author is Rebeca Sanz, who has a PhD in Biology, from the Cancer Prevention and Control Program. Victor Moreno, Adriana Lopez-Doriga and Henar Alonso, among others, are also listed as authors. […]
The article Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer has been published in Clinical Cancer Research journal. The main author is Rebeca Sanz, from the Cancer Prevention and Control Program at ICO. The main objective of the study was to characterize the colonomicst tumors at mutational level, by exome sequencing. After analyzing the results, […]
The article Altered pathways and colorectal cancer prognosis, published at BMC Med journal by Víctor Moreno and Rebeca Sanz-Pamplona, discusses the results published by Slattery et al. in the article “Improved survival among colon cancer patients with increased differentially expressed pathways”. The authors showed a differential gene expression analysis between tumor tissue and adjacent normal tissue based […]
Contact with us Cancer Prevention and Control Program Catalan Institute of Oncology ICO l’Hospitalet How to arrive to Catalan Institute of Oncology? Gran Via de l’Hospitalet, 199-203. 08908 L’Hospitalet de Llobregat e-mail: estudicolon@iconcologia.net Tel: +(34) 93 260 73 57 Metro station-Hospital de Bellvitge: Line 1 (Hospital – Ronda de la Torrassa) Line 2 (Hospital – Santa […]
What is a gene? A gene is a piece of DNA (genetic code) that contains information about how cells are working. Genes determine the inheritance of an individual. What is genetics? It is the study of genes, genetic variation and heredity in living organisms. What is a genetic test? It is a blood test which […]
What is colorectal cancer? Colorectal cancer is a malignant tumor that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lowest part of the body’s digestive system. It’s the most common cancer in Spain, and around 32,000 new cases are diagnosed each year. Approximately […]
I want to participate Who can partipate? Men or women, aged 50 to 69, who have undergone a fecal occult blood test (positive or negative). What can I do participate? Please call 93 260 71 22, or send us an e-mail to estudicolon@iconcologia.net.
Study objective It is a biomedical study promoted by the Catalan Institute of Oncology with the help of Bellvitge University Hospital, the Hospital of Viladecans and Moisès Broggi Hospital. It is designed to investigate genetic and environmental factors that could lead to the onset of colorectal cancer. We know that environmental risk factors (being overweight, […]
